Q4 CC is Friday morning and the current VMAT2 P2b trial for TD is an open trial so Management knows all their is to know and I bet the results are stella. No adverse events reported ect ect ect.
VMAT2 could be a significant PPS driver for investors and given big pharmas need for new revenue/drugs to fill their pipelines. The street IMO is looking at NBIX ...... buy buy buy
looking good, but not sure what happened to cause the jump.
Sentiment: Strong Buy
What a difference a day makes? Looks like defensive selling ahead of tomorrow's call. Understandable.
NBIX holding on to yesterdays gains today Can it go green this afternoon?????
Now that would be a huge PPS positive